QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TECX

QT73Tectonic Therapeutic, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
30.02
-0.04-0.13%
OverviewShort InterestFilings
TECXQT73Tectonic Therapeutic, Inc.·NASDAQ
OverviewShort InterestFilings
30.02-0.13%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own40.70%
Shs Outstand18.87M
Perf Week2.32%
Market Cap567.21MForward P/E-EPS next Y-5.68Insider Trans0.21%Shs Float-Perf Month10.00%
Enterprise Value334.95MPEG-EPS next Q-1.37Inst Own-Short Float-Perf Quarter-2.63%
Income-83946744.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y60.62%
Sales-P/B2.45EPS next Y-6.43%ROA-33.86%Short Interest-Perf YTD43.91%
Book/sh12.19P/C-EPS next 5Y-ROE-32.33%52W High36.03 -16.68%Perf Year46.37%
Cash/sh12.56P/FCF-EPS past 3/5Y-ROIC-39.58%52W Low14.39 108.62%Perf 3Y-
Dividend Est.-EV/EBITDA-4.16Sales past 3/5Y-Gross Margin0.00%Volatility4.16% 4.55%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-13.49%Oper. Margin0.00%ATR (14)1.92Perf 10Y-
Dividend Ex-Date-Quick Ratio18.51Sales Y/Y TTM-Profit Margin0.00%RSI (14)54.32Recom1.80
Dividend Gr. 3/5Y-Current Ratio18.51EPS Q/Q-44.09%SMA202.34%Beta1.45Target Price72.00
Payout0.00%Debt/Eq0.02Sales Q/Q-SMA503.59%Rel Volume0.53Prev Close30.06
Employees51LT Debt/Eq0.01EarningsAug 06SMA20030.17%Avg Volume200.74KPrice30.02
IPO DateJun 21, 2018Option/ShortYes / YesEPS/Sales Surpr.-15.52% -Net Debt/EBITDA2.88Volume106,749Change-0.13%
Analyst Ratings
DateActionAnalystRatingTarget
May-26-26UpgradeRaymond JamesOutperform → Strong Buy$81
Apr-13-26InitiatedStifelBuy$75
Jan-08-26ReiteratedTruist Financial$64 → $60
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A000
Gross Profit000
Selling, General and Administrative Excl. Other21178
Research and Development634137
Other Operating Expense
000
Operating Income-84-58-45
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-110-2
Net Income Before Taxes-73-58-43
Income Taxes100
Consolidated Net Income-74-58-43
Net Income From Continuing Operations-74-58-43
Net Income-74-58-43
EPS (Recurring)-4.05-3.93-11.59
EPS (Basic, Before Extraordinaries)-4.05-3.93-11.59
EPS (Diluted)-4.05-3.93-11.53
EBITDA-71-56-41
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding18154
Market Capitalization375——
Operating Lease Expense
———
Insider Trading Volume
$32.08$28.56$25.04$21.53$18.01● Close Price0.00K141.64K283.28K424.92K566.56KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Ruddy Marcella K.Chief Medical OfficerMay 04 '26Sale30.001,06531,95067,682May 06 12:00 AM
Ruddy Marcella K.Chief Medical OfficerApr 01 '26Sale31.051,00031,05068,747Apr 03 12:00 AM
Ruddy Marcella K.Chief Medical OfficerMar 06 '26Sale30.0010,000300,00069,747Mar 09 12:00 AM
McNamara PeterChief Scientific OfficerMar 06 '26Option Exercise3.365,43018,22661,547Mar 09 12:00 AM
McNamara PeterChief Scientific OfficerMar 06 '26Sale30.176,262188,93555,285Mar 09 12:00 AM
McNamara PeterChief Scientific OfficerMar 04 '26Sale25.001,65041,25058,832Mar 05 12:00 AM
McNamara PeterChief Scientific OfficerMar 03 '26Sale22.061,64936,37737,482Mar 05 12:00 AM
REICIN ALISEChief Executive OfficerFeb 11 '26Buy21.105,000105,500237,547Mar 05 12:00 AM
Schwabish MarcChief Business OfficerFeb 10 '26Option Exercise2.389,00021,42082,014Feb 12 12:00 AM
Lochner DanielChief Financial OfficerFeb 10 '26Buy21.616,000129,66032,044Feb 11 12:00 AM
REICIN ALISEChief Executive OfficerDec 31 '25Option Exercise2.3821,93252,198239,151Jan 05 12:00 AM
McNamara PeterChief Scientific OfficerDec 22 '25Option Exercise2.9814,00041,72040,879Dec 29 12:00 AM
SPRINGER TIMOTHY Adirector, 10 percent owner:Apr 11 '25Buy16.3163,1841,030,5314,334,846Apr 11 12:00 AM
SPRINGER TIMOTHY Adirector, 10 percent owner:Apr 10 '25Buy16.7353,950902,5834,325,368Apr 11 12:00 AM
SPRINGER TIMOTHY Adirector, 10 percent owner:Apr 09 '25Buy14.7624,789365,9004,317,276Apr 11 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR